1993
DOI: 10.1016/0920-1211(93)90083-j
|View full text |Cite
|
Sign up to set email alerts
|

Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
195
1
2

Year Published

1997
1997
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 310 publications
(210 citation statements)
references
References 61 publications
9
195
1
2
Order By: Relevance
“…Selective lesion of layer III neurons in the entorhinal cortex using focal injections of aminooxyacetic acid has been shown to disrupt inhibitory processes in the hippocampus area CA1, leading to a hypothesis postulating that partial loss of layer III entorhinal cortical neurons may contribute to reductions in feedforward inhibition in area CA1, amplifying the temporoammonic pathway (Denslow et al, 2001). In patients with TLE and in pilocarpine animal models of epilepsy, cell loss in layer III of the entorhinal cortex has been shown (Du et al, 1993(Du et al, , 1995 (supplemental Fig. 3, available at www.jneurosci.org as supplemental material).…”
Section: Discussionmentioning
confidence: 99%
“…Selective lesion of layer III neurons in the entorhinal cortex using focal injections of aminooxyacetic acid has been shown to disrupt inhibitory processes in the hippocampus area CA1, leading to a hypothesis postulating that partial loss of layer III entorhinal cortical neurons may contribute to reductions in feedforward inhibition in area CA1, amplifying the temporoammonic pathway (Denslow et al, 2001). In patients with TLE and in pilocarpine animal models of epilepsy, cell loss in layer III of the entorhinal cortex has been shown (Du et al, 1993(Du et al, , 1995 (supplemental Fig. 3, available at www.jneurosci.org as supplemental material).…”
Section: Discussionmentioning
confidence: 99%
“…TLE patients present with a pattern of brain damage known as Ammon's horn sclerosis (or mesial temporal sclerosis) that is typically characterized by neuronal loss in hippocampal CA1/CA3 subfields, dentate hilus, layer III of the medial EC, and amygdala (Gloor, 1991(Gloor, , 1997Houser, 1999;Du et al, 1993). Similar histopathological changes have been reported to occur in laboratory animals by injecting convulsant drugs such as pilocarpine or kainic acid, or by repetitive electrical stimulation of limbic pathways (Ben-Ari, 1985;Cavalheiro et al, 1991;Curia et al, 2008;Du et al, 1995).…”
Section: Gaba a Receptor-mediated Inhibition In Temporal Lobe Epilepsymentioning
confidence: 99%
“…On histopathology, HS is characterized by segmental neuronal loss and gliosis within the hippocampal formation,2, 3 yet postmortem studies indicate neuronal loss and gliosis is also present in a proportion of patients in the amygdala,4 entorhinal cortex,5 temporal neocortex6 and extra‐temporal neocortex 2, 7…”
Section: Introductionmentioning
confidence: 99%